After this article [1,2] was published, concerns were raised that the article cited as Reference 9 was retracted before publication of [1,2]. Additionally, the PLOS One Editors have concerns about the article’s compliance with the PLOS Authorship policy.
In light of the cumulative issues, the PLOS One Editors issue this Expression of Concern. Readers are advised to interpret the article [1,2] with caution.
References
- 1. Thahiem S, Ihsan M, Muneer H, Sohail A, Khan M, Murtaza I, et al. Targeting NLRP3 and AIM2 signaling pathways by Viscosol alleviates metabolic dysregulations induced inflammatory responses in diabetic neuro- and nephropathy: An in silico and in vivo study. PLoS One. 2025;20(4):e0313816. pmid:40173145
- 2. Thahiem S, Ihsan M, Muneer H, Sohail A, Khan M, Murtaza I, et al. Correction: Targeting NLRP3 and AIM2 signaling pathways by Viscosol alleviates metabolic dysregulations induced inflammatory responses in diabetic neuro- and nephropathy: An in silico and in vivo study. PLoS One. 2025;20(12):e0338855. pmid:41379829
Citation: The PLOS One Editors (2026) Expression of Concern: Targeting NLRP3 and AIM2 signaling pathways by Viscosol alleviates metabolic dysregulations induced inflammatory responses in diabetic neuro- and nephropathy: An in silico and in vivo study. PLoS One 21(2): e0342732. https://doi.org/10.1371/journal.pone.0342732
Published: February 12, 2026
Copyright: © 2026 The PLOS One Editors. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.